HE homepage

Aidence, a Netherlands-based medical imaging company, has raised about $11.3 million in funding to expand its AI-powered platform for detecting lung cancer.

CivicaRx, the not-for-profit entity created last year by a group of health systems and hospitals, is planning to achieve its goals of lowering drug prices and addressing shortages in hospitals by working directly with pharmaceutical companies and buying drugs, Bloomberg reported.

The Royal Australia and New Zealand College of Radiologists (RANZCR) recently unveiled a draft of ethical guidelines for the emerging use of machine learning and AI in medicine.

Some companies in particular are rising above the fray with their innovative solutions, according to Fast Company, which ranked the most innovative companies for 2019 across industries and overall.

Opioid-related deaths, particularly those associated with synthetic opioids, have impacted the eastern states, according to new research published in JAMA Network Open. Washington D.C. had the highest increase in death rates across the U.S.—more than tripling every year since 2013.

After being challenged by an ALS group to study the disease closer by using data, a machine learning researcher has developed an AI platform designed to monitor and predict the progression of neurodegenerative diseases.